Correlation Between Better Therapeutics and Entera Bio
Can any of the company-specific risk be diversified away by investing in both Better Therapeutics and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Better Therapeutics and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Better Therapeutics and Entera Bio, you can compare the effects of market volatilities on Better Therapeutics and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Better Therapeutics with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Better Therapeutics and Entera Bio.
Diversification Opportunities for Better Therapeutics and Entera Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Better and Entera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Better Therapeutics and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Better Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Better Therapeutics are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Better Therapeutics i.e., Better Therapeutics and Entera Bio go up and down completely randomly.
Pair Corralation between Better Therapeutics and Entera Bio
If you would invest (100.00) in Better Therapeutics on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Better Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Better Therapeutics vs. Entera Bio
Performance |
Timeline |
Better Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Entera Bio |
Better Therapeutics and Entera Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Better Therapeutics and Entera Bio
The main advantage of trading using opposite Better Therapeutics and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Better Therapeutics position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.Better Therapeutics vs. ABVC Biopharma | Better Therapeutics vs. Indaptus Therapeutics | Better Therapeutics vs. Pasithea Therapeutics Corp | Better Therapeutics vs. Forte Biosciences |
Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |